Answers are grounded in this paper and cite their sources.
in cardiac surgery. The review included all studies published from January 2013 to December 2020. We conclude that CardioCel is a strong, flexible tissue substitute with good handling characteristics and a low incidence of thrombosis, aneurysm formation, infection, or structural degeneration. It can be used for a variety of intracardiac and extracardiac repairs of congenital heart defects in all age groups with good durability at mid-term follow-up. However, the use of CardioCel in certain positions requires caution. Information on the long-term performance of CardioCel is lacking.
No takes yet. Share an insight, caveat, or question.
Patukale et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: